Qingpu Liu Selected Research

1-Deoxynojirimycin (1 Deoxynojirimycin)

12/2015

1-Deoxynojirimycin Alleviates Insulin Resistance via Activation of Insulin Signaling PI3K/AKT Pathway in Skeletal Muscle of db/db Mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qingpu Liu Research Topics

Disease

2	Diabetic Nephropathies (Diabetic Nephropathy) 09/2019 - 01/2019
2	Insulin Resistance 02/2016 - 12/2015
1	Inflammation (Inflammations) 09/2019
1	Necrosis 09/2019
1	Proteinuria 09/2019
1	Body Weight (Weight, Body) 12/2015
1	Hyperglycemia 12/2015
1	Diabetes Mellitus 12/2015

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 09/2019 - 02/2016
2	catalpolIBA 09/2019 - 01/2019
2	IridoidsIBA 09/2019 - 01/2019
2	GlycosidesIBA 09/2019 - 01/2019
2	Insulin (Novolin)FDA Link 02/2016 - 12/2015
1	ImmunosorbentsIBA 09/2019
1	Interleukin-6 (Interleukin 6)IBA 09/2019
1	Glucose (Dextrose)FDA LinkGeneric 02/2016
1	1-Deoxynojirimycin (1 Deoxynojirimycin)IBA 12/2015
1	Blood Glucose (Blood Sugar)IBA 12/2015
1	GlucosidasesIBA 12/2015
1	Therapeutic UsesIBA 12/2015